CVS Group (CVSGF)
CVS Statistics
Share Statistics
CVS has 71.74M shares outstanding. The number of shares has increased by 0.03% in one year.
| Shares Outstanding | 71.74M |
| Shares Change (YoY) | 0.03% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 125.52 and the forward PE ratio is null. CVS's PEG ratio is -1.47.
| PE Ratio | 125.52 |
| Forward PE | n/a |
| PS Ratio | 1.2 |
| Forward PS | n/a |
| PB Ratio | 2.99 |
| P/FCF Ratio | 31.51 |
| PEG Ratio | -1.47 |
Enterprise Valuation
CVS has an Enterprise Value (EV) of 1.05B.
| EV / Sales | 1.62 |
| EV / EBITDA | 11.38 |
| EV / EBIT | 15.48 |
| EV / FCF | 42.49 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.09 |
| Quick Ratio | 0.82 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 11.65 |
| Interest Coverage | 4.03 |
Financial Efficiency
Return on Equity is 2.38% and Return on Invested Capital is 5.99%.
| Return on Equity | 2.38% |
| Return on Assets | 0.9% |
| Return on Invested Capital | 5.99% |
| Revenue Per Employee | $71,922.22 |
| Profits Per Employee | $688.89 |
| Employee Count | 9,000 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 11.62 |
Taxes
| Income Tax | 11.8M |
| Effective Tax Rate | 30.89% |
Stock Price Statistics
The stock price has increased by 32.56% in the last 52 weeks. The beta is 1.06, so CVS's price volatility has been higher than the market average.
| Beta | 1.06 |
| 52-Week Price Change | 32.56% |
| 50-Day Moving Average | 14.33 |
| 200-Day Moving Average | 13.09 |
| Relative Strength Index (RSI) | 99.84 |
| Average Volume (20 Days) | 52 |
Income Statement
In the last 12 months, CVS had revenue of 647.3M and earned 6.2M in profits. Earnings per share was 0.09.
| Revenue | 647.3M |
| Gross Profit | 277.9M |
| Operating Income | 50.8M |
| Net Income | 6.2M |
| EBITDA | 92.2M |
| EBIT | 50.8M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 16.5M in cash and 287.8M in debt, giving a net cash position of -271.3M.
| Cash & Cash Equivalents | 16.5M |
| Total Debt | 287.8M |
| Net Cash | -271.3M |
| Retained Earnings | 211.2M |
| Total Assets | 690M |
| Working Capital | 10.5M |
Cash Flow
In the last 12 months, operating cash flow was 67.8M and capital expenditures -43.1M, giving a free cash flow of 24.7M.
| Operating Cash Flow | 67.8M |
| Capital Expenditures | -43.1M |
| Free Cash Flow | 24.7M |
| FCF Per Share | 0.34 |
Margins
Gross margin is 42.93%, with operating and profit margins of 7.85% and 0.96%.
| Gross Margin | 42.93% |
| Operating Margin | 7.85% |
| Pretax Margin | 5.9% |
| Profit Margin | 0.96% |
| EBITDA Margin | 14.24% |
| EBIT Margin | 7.85% |
| FCF Margin | 3.82% |
Dividends & Yields
CVSGF pays an annual dividend of $0.15, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | $0.15 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | 6.67% |
| Payout Ratio | 43.06% |
| Earnings Yield | 0.8% |
| FCF Yield | 3.17% |
Analyst Forecast
Currently there are no analyst rating for CVSGF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 3.71 |
| Piotroski F-Score | 4 |